Overview

Carotenoids for Collision Athletes

Status:
COMPLETED
Trial end date:
2024-11-22
Target enrollment:
Participant gender:
Summary
This is a supplement study being conducted to find out if collision sport athletes who are exposed to repetitive head impacts while supplementing with carotenoids will have decreased pro-inflammatory blood biomarkers, increases in macular pigment optical density, improved contrast sensitivity, greater retinal nerve fiber thickness, and better overall visual quality of life scores compared to collision athletes taking a placebo.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Penn State University
Collaborators:
MacuHealth
Orlando Regional Medical Center